XTNT · Xtant Medical Holdings, Inc. · Metrics
$0.28
+0.01 (+2.07%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$40.40M
Shares
140.29M
Volume · Oct 27
87.39K
Avg daily vol (3M)
1.67M
XTNT metrics
96 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$0.28
Market cap
$40.40M
Price action
20 metricsPrice change (1W)
-7.3%
Price change (30D)
-21.1%
Price change (3M)
-34.7%
Price change (6M)
-48.9%
Price change (YTD)
-64.0%
Price change (1Y)
-68.1%
Trailing year
Price change (5Y)
-76.4%
52-week high
$0.92
52-week low
$0.28
Change from 52-week high
-69.5%
Change from 52-week low
+2.1%
Annualized volatility
65.0%
Annualized volatility (3M)
86.8%
Beta
0.4
RSI (14D)
36.5
Price vs SMA 50
-16.2%
Price vs SMA 200
-39.9%
Avg volume (3M)
1.67M
Relative volume
0.1
Average dollar volume
$630,307
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
140.29M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.4×
reciprocal yield 263.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 271.1%
P / book
1.0
reciprocal yield 99.0%
FCF yield
-1.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
70.9
reciprocal yield 1.4%
Earnings yield
-27.6%
Historical valuation
8 metricsP / E historical average (3Y)
60.6×
reciprocal yield 1.6%
P / E historical average (5Y)
60.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
0.9×
reciprocal yield 108.4%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 92.6%
EV / EBIT historical average (3Y)
897.2×
reciprocal yield 0.1%
EV / EBIT historical average (5Y)
758.8×
reciprocal yield 0.1%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
22.4×
reciprocal yield 4.5%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-11
Profitability
9 metricsGross margin
59.4%
Operating margin
-9.6%
Trailing 12 months
Net margin
-10.2%
Gross profit (TTM)
$65.05M
Operating profit (TTM)
−$10.49M
Net income (TTM)
−$11.14M
Trailing 12 months
Diluted EPS (TTM)
$-0.08
FCF margin
-0.6%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-35.0%
Year over year
Net income growth YoY
-365.2%
Revenue (TTM)
$109.53M
Trailing 12 months
EPS growth YoY
-450.0%
Shares change YoY
-5.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+32.2%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-27.8%
Return on assets
-14.0%
Debt / equity
0.3
Current ratio
2.2
EBITDA (TTM)
−$6.47M
Free cash flow (TTM)
−$696,000
Quick ratio
1.1
Interest coverage
-3.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.14M
Latest balance sheet
Cash & equivalents
$9.87M
Total assets
$79.67M
Total debt
$11.01M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$570,000
Capital expenditures (TTM)
$1.27M
R&D (TTM)
$2.22M
SG&A (TTM)
—
Stock compensation (TTM)
$2.96M
R&D / revenue
2.0%
Stock compensation / revenue
2.7%
Ownership (13F)
9 metrics13F filers
32
13F filer change QoQ
-2
Institutional ownership
57.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
54.2%
Private-fund adviser ownership
54.1%
Active holders' share change QoQ
-0.6%
Holder tenure
11.4
Price vs estimated holder cost
-30.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
1.7%
Short interest
3 metricsShort interest
0.2%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
37 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—